The latest cancer drugs news
Browsing: Cancer Drug News
The long read: The cancer drugs in your bathroom cabinet
By Linda Geddes – The Guardian. Researchers have had promising results treating tumours with everyday medicines.…
ASCO 2016: Cancer drug retail prices vastly different between countries
A pilot study revealed large differences in median retail prices for 23 cancer drugs in…
ASCO 2016: Antibody drug conjugate shows early promise in small cell lung cancer
Early findings from a first-in-human clinical trial showed that antibody drug conjugate (ADC) rovalpituzumab tesirine…
Surrogate endpoints poor proxy for survival in cancer drug approval process
Surrogate endpoints used to support the majority of new cancer drugs approved in the U.S.…
ASCO 2016: Primary tumour location predicts survival in metastatic colorectal cancer
A retrospective analysis of data from a large, federally funded clinical trial finds that the…
Unfair if rare: should the PBS change the way it lists cancer drugs?
By Ian Olver, University of South Australia. The Pharmaceutical Benefits Scheme (PBS) spends over A$9 billion…
Can gender play a role in determining cancer treatment choices?
It is well known that men and women differ in terms of cancer susceptibility, survival…
Why cancer drugs can’t take the pressure
A major reason why cancer drugs fail is that they cannot penetrate the high-pressure environment…
Value of cancer drugs in nine countries
The May issue of Health Affairs includes a study examining real-world cancer drug consumption in nine countries.…
New cancer drugs could treat lethal resistant prostate cancers
Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit…